Metabolic barriers to immunotherapy in renal cell carcinoma.

被引：2
|
作者：
Beckermann, Katy
Siska, Peter
Mason, Frank
Rathmell, Kimryn
Rathmell, Jeffrey C.
机构：
[1] Vanderbilt Univ, Nashville, TN USA
[2] Vanderbilt Univ, Ingram Canc Ctr, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.11560
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11560
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Sarcomatoid renal cell carcinoma.: A rare and aggressive variation of primary renal cell carcinoma
    Bannowsky, A.
    Leuschner, I.
    Schiller, H.
    Bothe, K.
    Osmonov, D.
    Juenemann, K-P
    Hautmann, S.
    UROLOGE, 2007, 46 (04): : 406 - 411
  • [32] Cell cycle regulations in primary renal cell carcinoma.
    Mu, XC
    Hou, J
    Nazeer, T
    Ross, JS
    MODERN PATHOLOGY, 1998, 11 (01) : 90A - 90A
  • [33] An estimate of premature deaths averted with immunotherapy in treating Brazilian patients with advanced clear cell renal cell carcinoma.
    Lenz, Gabriel
    Peruzzo, Nicolas
    Arraes, Cecilia
    Lopes, Gilberto
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [34] A brief symptom index for renal cell carcinoma.
    Eton, D. T.
    Cello, D.
    Bacik, J.
    Motzer, R. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 240S - 240S
  • [35] Electrolyte abnormalities and the incidence of renal cell carcinoma.
    Young, B
    Remler, R
    Weinman, S
    Weiss, NS
    Shapiro, JA
    Williams, MA
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2000, 151 (11) : S76 - S76
  • [36] Racial and gender disparities in renal cell carcinoma.
    Mozayen, Mohammad
    Tesfaye, Anteneh
    Katato, Khalil
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [37] Dietary patterns and the risk of renal cell carcinoma.
    Handa, KA
    Kreiger, N
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (11) : S41 - S41
  • [38] Lymphopenia as a prognostic factor in renal cell carcinoma.
    Mozayen, Mohammad
    Tesfaye, Anteneh
    Katato, Khalil
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [39] Inhibition of angiogenesis for treatment of renal cell carcinoma.
    Takahashi, A
    Sasamura, H
    Miyao, N
    Yanase, M
    Masumori, N
    Oda, T
    Itoh, N
    Horita, H
    Tsukamoto, T
    JOURNAL OF UROLOGY, 1998, 159 (05): : 168 - 168
  • [40] Immune cell phenotyping of clear cell renal cell carcinoma.
    Ghanaat, Mazyar
    Liu, Ming
    Manley, Brandon
    Kashan, Mahyar
    Becerra, Maria
    Redzematovic, Almedina
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
12345